Protein Recognition of Gold-Based Drugs: 3D Structure
of the Complex Formed When Lysozyme Reacts with Aubipy<sup>c</sup>
- Publication date
- Publisher
Abstract
The
structure of the adduct formed in the reaction between Aubipy<sup>c</sup>, a cytotoxic organogold(III) compound, and the model protein
hen egg white lysozyme (HEWL) has been solved by X-ray crystallography.
It emerges that Aubipy<sup>c</sup>, after interaction with HEWL, undergoes
reduction of the gold(III) center followed by detaching of the cyclometalated
ligand; the resulting naked gold(I) ion is found bound to the protein
at Gln121. A direct comparison between the present structure and those
previously solved for the lysozyme adducts with other gold(III) compounds
demonstrates that coordinated ligands play a key role in the protein–metallodrug
recognition process. Structural data support the view that gold(III)-based
antitumor prodrugs are activated through metal reduction